Protocol to purify recombinant inflammatory caspases and assess their catalytic activity in vitro.


Journal

STAR protocols
ISSN: 2666-1667
Titre abrégé: STAR Protoc
Pays: United States
ID NLM: 101769501

Informations de publication

Date de publication:
16 12 2022
Historique:
received: 02 09 2022
revised: 26 09 2022
accepted: 20 10 2022
entrez: 3 1 2023
pubmed: 4 1 2023
medline: 6 1 2023
Statut: ppublish

Résumé

The inflammatory caspases, such as caspase-1, caspase-4, or caspase-11, are key enzymes in mammalian innate immunity as they control inflammasome-dependent inflammation. Assessing the specific proteolytic activities of these caspases in the context of a cell remains challenging, which is why in vitro studies of their catalytic activity have proven useful. Herein, we describe a detailed protocol for the purification of recombinant inflammatory caspases after heterologous expression in bacteria and how to assess and quantify cleavage of full-length protein substrates. For complete details on the use and execution of this protocol, please refer to Devant et al. (2021).

Identifiants

pubmed: 36595884
pii: S2666-1667(22)00728-6
doi: 10.1016/j.xpro.2022.101848
pmc: PMC9668568
pii:
doi:

Substances chimiques

Caspases EC 3.4.22.-
Inflammasomes 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

101848

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK034854
Pays : United States

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests J.C.K. consults and holds equity in Corner Therapeutics, Larkspur Biosciences, and Neumora Therapeutics. None of these relationships influenced the manuscript.

Références

Cold Spring Harb Protoc. 2020 Jun 1;2020(6):102194
pubmed: 32482902
Curr Protoc Protein Sci. 2002 Feb;Chapter 21:21.8.1-21.8.16
pubmed: 18429233
Eur J Immunol. 2015 Oct;45(10):2911-7
pubmed: 26174085
Eur J Immunol. 2015 Oct;45(10):2927-36
pubmed: 26173909
Methods Mol Biol. 2014;1133:3-39
pubmed: 24567092
J Biol Chem. 2020 Aug 7;295(32):11292-11302
pubmed: 32554464
Eur J Immunol. 2015 Oct;45(10):2918-26
pubmed: 26173988
Sci Immunol. 2021 Aug 10;6(62):
pubmed: 34734155
J Biol Chem. 2018 May 4;293(18):7058-7067
pubmed: 29414788
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Methods Enzymol. 2000;322:91-100
pubmed: 10914007
Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):5669-74
pubmed: 22451931

Auteurs

Pascal Devant (P)

Division of Gastroenterology, Boston Children's Hospital and Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA. Electronic address: pdevant@g.harvard.edu.

Jonathan C Kagan (JC)

Division of Gastroenterology, Boston Children's Hospital and Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA. Electronic address: jonathan.kagan@childrens.harvard.edu.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
C-Reactive Protein Humans Biomarkers Inflammation
Humans Immune Checkpoint Inhibitors Lung Neoplasms Prognosis Inflammation

Classifications MeSH